01.08.15
Evolva Holding SA announced successful completion of first part of its research and development collaboration with L'Oréal. The parties have agreed to move into next phase of multi-year program.
Under this collaboration, which started in February 2014, Evolva and L’Oréal are applying Evolva’s innovative fermentation technology to develop a yeast strain optimized for sustainable and cost-effective production of a strategically important cosmetics ingredient. For a closer look at Evolva's technology, click here.
With the completion of the first work package, Fabien Cabirol, L’Oréal’s new global head of biotechnologies department, said “With this partnership L’Oréal aims to leverage on Evolva strong technological platform to develop innovative cosmetic ingredients with perceivable performance and measurable sustainability benefits. L’Oréal in-house expertise combined with Evolva flexible yeast platform opens opportunities to meet the needs and aspirations of consumers.”
Evolva CEO Neil Goldsmith said. “We are pleased to have demonstrated to L’Oréal our capabilities, and the strength and elegance of our platform.”
Under this collaboration, which started in February 2014, Evolva and L’Oréal are applying Evolva’s innovative fermentation technology to develop a yeast strain optimized for sustainable and cost-effective production of a strategically important cosmetics ingredient. For a closer look at Evolva's technology, click here.
With the completion of the first work package, Fabien Cabirol, L’Oréal’s new global head of biotechnologies department, said “With this partnership L’Oréal aims to leverage on Evolva strong technological platform to develop innovative cosmetic ingredients with perceivable performance and measurable sustainability benefits. L’Oréal in-house expertise combined with Evolva flexible yeast platform opens opportunities to meet the needs and aspirations of consumers.”
Evolva CEO Neil Goldsmith said. “We are pleased to have demonstrated to L’Oréal our capabilities, and the strength and elegance of our platform.”